Cys-C Rapid Quantitative Test

Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.

HbA1c Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

MAU Rapid Quantitative Test

MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any signiﬁcant rise in serum creatinine.

HbA1c Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

5 in 1 (cTnI/ CK-MB/ Myo/ NT-proBNP/ D-Dimer) Rapid Quantitative Test

Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain, suspected Acute Coronary Syndrome(ACS) and Heart Failure(HF), etc.

NGAL Rapid Quantitative Test

FLI-4000 FIA Immunoassay Analyzer

FLI-4000 is an automatic immunoassay analyzer that measures the concentration of targeted analyte in human blood and urine. FLI-4000 is designed for processing / analyzing large volumes of samples and can carry up to 40 tests per hour (depending on the type of item).

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

Specimen Types	WB/Plasma
Specimen Capacity	WB:15μL; Plasma:10μL
Reaction Time	5 min
Sample Capacity	80μL
Detection Range	0.2-8mg/L

Fluorescence Immunoassay

Diabetes and Renal Injury Marker

Cys-C Rapid Quantitative Test